An exploratory, observational study to evaluate the efficacy and safety of daptomycin in treating neutropenic patients with fever due to known or suspected gram positive infections in adult hemato-oncology patients.

Trial Profile

An exploratory, observational study to evaluate the efficacy and safety of daptomycin in treating neutropenic patients with fever due to known or suspected gram positive infections in adult hemato-oncology patients.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs Daptomycin (Primary)
  • Indications Febrile neutropenia; Gram-positive infections
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 15 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top